Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

What is the optimal antithrombotic strategy in primary percutaneous coronary intervention?

Current opinion in cardiology - 1 Jul 2012

Sergie Ziad, Mehran Roxana, Stone Gregg W

Abstract excerpt

PURPOSE OF REVIEW: Major bleeding in the setting of acute coronary syndromes and percutaneous coronary intervention has been associated with increased short-term and long-term risk for adverse cardiac events and mortality. Recent studies on antithrombotic agents in this setting have highlighted t...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Coronary Syndrome
Share to Angioplasty, Balloon, Coronary
Share to Antithrombins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibrinolytic Agents

Share to Hemorrhage

Share to Myocardial Infarction

Share to Peptide Fragments

Share to United States

Source

Identifiers

PMID: 22565142
DOI: 10.1097/HCO.0b013e3283540828

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22565142-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

What is the optimal antithrombotic strategy in primary percutaneous coronary intervention?PMID 22565142Read ↗

Antithrombotic Approaches in Acute Coronary Syndromes: Optimizing Benefit vs Bleeding Risks.Semantic proximity Read ↗

Bleeding in cardiac patients prescribed antithrombotic drugs: Electronic health record phenotyping algorithms, incidence, trends and prognosisSemantic proximity Read ↗

Antithrombotic Therapy in Patients Undergoing Transcatheter Aortic Valve ImplantationSemantic proximity Read ↗

Bleeding with anticoagulation therapy - who is at risk, and how best to identify such patients.Semantic proximity Read ↗

Initial ticagrelor monotherapy strategy is effective and safe in patient with high bleeding risk after percutaneous coronary intervention: series case reports and literature reviewSemantic proximity Read ↗

Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: A longitudinal cohort studySemantic proximity Read ↗

North American Thrombosis Forum, AF Action Initiative Consensus Document.Semantic proximity Read ↗

Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.Semantic proximity Read ↗

Re-starting anticoagulation and antiplatelets after gastrointestinal bleeding: A systematic reviewSemantic proximity Read ↗

Antithrombotic Therapy in Atrial Fibrillation Patients with Prior Complex Percutaneous Coronary Intervention: A Secondary Analysis of the Randomized ADAPT AF-DES TrialSemantic proximity Read ↗

Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go?Semantic proximity Read ↗

Assessment of bleeding risk in patients with coronary artery disease on dual antiplatelet therapy. A systematic review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.